Immediate Impact
2 from Science/Nature 62 standout
Citing Papers
Nanotechnology for enhanced nose-to-brain drug delivery in treating neurological diseases
2024 Standout
Possibilities and limitations of antisense oligonucleotide therapies for the treatment of monogenic disorders
2024 Standout
Works of Claudio Semplicini being referenced
Functional changes in Becker muscular dystrophy: implications for clinical trials in dystrophinopathies
2016
Enzyme Replacement Therapy for Pompe Disease
2011
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Claudio Semplicini | 180 | 205 | 232 | 25 | 460 | |
| K. Eger | 202 | 224 | 151 | 18 | 452 | |
| Robert‐Yves Carlier | 149 | 132 | 246 | 36 | 527 | |
| Lara R. DeRuisseau | 116 | 285 | 158 | 28 | 571 | |
| Françoise Bouhour | 110 | 166 | 235 | 18 | 447 | |
| Paola De Filippi | 191 | 251 | 112 | 25 | 480 | |
| Tracey Willis | 71 | 105 | 333 | 44 | 566 | |
| Gilles Morin | 151 | 220 | 157 | 22 | 442 | |
| J.H.J. Wokke | 232 | 291 | 95 | 15 | 513 | |
| Nesrin Karabul | 222 | 445 | 99 | 24 | 554 | |
| Atze J. Bergsma | 150 | 229 | 352 | 20 | 544 |
All Works
Login with ORCID to disown or claim papers
Loading papers...